[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519486":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":27,"locations":37,"responsibleParty":56,"collaborators":32,"id":59,"slug":60,"hasResults":61,"nctId":62,"briefTitle":63,"officialTitle":64,"acronym":65,"eligibilityCriteria":66,"healthyVolunteers":61,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":32,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":40,"whyStopped":32,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":89,"completionDateStruct":91,"leadSponsor":93,"locationsCount":94},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention group","EXPERIMENTAL","Receive leucine on a daily basis for 10 weeks.",[13],"Dietary Supplement: Dietary Supplement: Leucine",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DIETARY_SUPPLEMENT","Dietary Supplement: Leucine","150mg\u002Fkg body mass\u002Fday",[9],[21],"Amino Acid",[23],{"name":24,"affiliation":25,"role":26},"Kaat Desloovere, Prof. dr.","Department of Rehabilitation Sciences, KU Leuven, Belgium","PRINCIPAL_INVESTIGATOR",[28,34],{"name":29,"role":30,"phone":31,"phoneExt":32,"email":33},"Ineke Verreydt","CONTACT","+3216341016",null,"ineke.verreydt@kuleuven.be",{"name":35,"role":30,"phone":32,"phoneExt":32,"email":36},"Lauraine Staut","lauraine.staut@kuleuven.be",[38],{"facility":39,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"UZ Leuven","RECRUITING","Leuven","Vlaams-Brabant","3000","Belgium","BE",{"type":47,"coordinates":48},"Point",[49,50],4.70093,50.87959,{"lat":50,"lon":49},[53],{"name":24,"role":30,"phone":54,"phoneExt":32,"email":55},"+3216338009","kaat.desloovere@uzleuven.be",{"type":26,"investigatorFullName":57,"investigatorTitle":58,"investigatorAffiliation":5,"oldNameTitle":32,"oldOrganization":32},"Kaat Desloovere","Prof. dr.","100519486","feasibility-nutritional-supplements-for-muscle-growth-in-cp-100519486",false,"NCT06044168","Feasibility Nutritional Supplements for Muscle Growth in CP","Feasibility Study: Nutritional Supplements to Support Muscle Growth in Children With Cerebral Palsy","Nut-CP","Inclusion Criteria:\n\nSpastic Cerebral Palsy (diagnosed by a neuro-pediatrician from the CP Reference Centre of the University Hospital Leuven)\n\n* Uni- of bilateral involvement\n* Level II or III on the Gross Motor Function Classification System (GMFCS)\n* Muscle volume for the medial gastrocnemius (target muscle) of at least 20% compared to the expected muscle volume in age-matched typically developing children\n\nExclusion Criteria:\n\n* Presence of dyskinesia or ataxia\n* Severe co-morbidities\n* Botulinum toxin treatment ten months prior to assessment\n* Previous orthopedic or neurosurgery\n* Severe ankle deformities preventing fitting in test positions\n* Ankle range of motion (ROM) \\\u003C30% of normal values","ALL","4 Years","10 Years",{"count":71,"type":72},5,"ESTIMATED","INTERVENTIONAL",[75],"NA","The purpose of this study is to investigate the feasibility of a 10-week plan with a nutritional supplement (leucine) and to perform pilot analyses on the effect of leucine on macroscopic muscle morphology in children with cerebral palsy.",[78],"Spastic Cerebral Palsy",[78,80,81,82,83,84],"3D freehand ultrasound","Muscle morphology","Nutritional supplements","Leucine","Feasibility","2026-05-04",{"date":87,"type":88},"2026-05-05","ACTUAL",{"date":90,"type":88},"2023-07-31",{"date":92,"type":72},"2027-12",{"name":5,"class":6},1]